However, the recent identification that CLIC1 activity is necessary for GSC proliferation, self-renewal and invasiveness, while it is dispensable for most non-transformed normal cell populations, opened new perspectives in the potential development of new therapeutics for this still incurable tumor. The gene discussed is CLIC1; the disease is neoplasm.